STOCK TITAN

Teleflex Incorporated - TFX STOCK NEWS

Welcome to our dedicated news page for Teleflex Incorporated (Ticker: TFX), a resource for investors and traders seeking the latest updates and insights on Teleflex Incorporated.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Teleflex Incorporated's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Teleflex Incorporated's position in the market.

Rhea-AI Summary
Teleflex Incorporated commits to achieving net-zero greenhouse gas emissions by 2050, validated by the Science Based Targets initiative. The company aims to reduce absolute emissions by significant percentages by 2032 and 2050, aligning with climate science goals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Rhea-AI Summary
Teleflex Incorporated (TFX) declares a quarterly cash dividend of $0.34 per share of common stock, payable on March 15, 2024, to shareholders of record as of March 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.28%
Tags
dividends
-
Rhea-AI Summary
Teleflex Incorporated (TFX) reported solid financial results for Q4 2023 and full year 2023, with revenue growth and adjusted EPS exceeding prior year figures. The company provided optimistic guidance for 2024, emphasizing growth strategies and capital allocation. Despite a decrease in GAAP EPS, adjusted EPS is expected to grow in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.28%
Tags
earnings
Rhea-AI Summary
Liam Kelly, Chairman, President, and CEO of Teleflex Incorporated (TFX), will speak at the 45th Annual Raymond James Institutional Investors Conference. The live webcast will be available on the Teleflex website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
conferences
-
Rhea-AI Summary
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update on February 22, 2024. Participants can pre-register and access the call through the company's website or by telephone. An audio replay will also be available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
earnings
-
Rhea-AI Summary
Teleflex Incorporated (NYSE: TFX) announced the availability of Titan SGS™ Standard Staple Line Reinforcement with GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement, a new option for bariatric surgeons. The product is designed to support staple line strength and reduce leaks or bleeds, expanding device selection for surgeons. The FDA clearance for this product means that surgeons who prefer staple line reinforcement now have that option with the Titan SGS™ Stapler.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
none
Rhea-AI Summary
Teleflex Incorporated (NYSE: TFX) CEO Liam Kelly to Speak at 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
conferences
-
Rhea-AI Summary
Teleflex Incorporated (TFX) has been awarded the Peripheral Access purchasing agreement with Premier, Inc., effective December 1st, 2023. This agreement allows Premier members to take advantage of special pricing and terms for Teleflex’s Peripheral Access products, including Peripherally Inserted Central Catheters (PICCs), PICC navigation equipment, and Midlines. The company is committed to delivering vascular access products designed to benefit clinicians and patients, while protecting against vascular access-related complications. Through its Arrow™ Peripheral Access products, Teleflex has recently refreshed the portfolio to optimize patient outcomes, reduce catheter colonization of major central line-associated infections (CLABSI) causing pathogens, and streamline insertion procedures. The new agreement with Premier is a significant opportunity for Teleflex to continue supporting healthcare providers in their efforts to reduce vascular-related complications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
none
-
Rhea-AI Summary
Teleflex Incorporated (NYSE: TFX) announced the first patient enrollment in a clinical registry to examine contemporary on-label use of the MANTA™ Vascular Closure Device (VCD) in standard of care transcatheter aortic valve replacement (TAVR) procedures. The ACCESS-MANTA™ Registry will enroll at least 250 patients in up to 15 major TAVR institutions across the US and Canada. The primary objectives are safety and effectiveness, evaluating VCD large bore access site-related complications within 30 days of the TAVR procedure, time to hemostasis, technical success, treatment success, ambulation success, discharge readiness, and procedure time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
none
Rhea-AI Summary
Teleflex Incorporated (NYSE:TFX) announced a new peer-reviewed study in the Nature journal Prostate Cancer and Prostatic Diseases reinforcing the UroLift™ System as the gold standard in minimally invasive surgical treatment for benign prostatic hyperplasia. The study evaluates complication and retreatment rates after BPH treatment with leading surgical and MIST, suggesting that within one year of BPH surgery, 1 in 20 patients may require retreatment regardless of the treatment method.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.96%
Tags
none
Teleflex Incorporated

NYSE:TFX

TFX Rankings

TFX Stock Data

10.64B
46.90M
0.23%
98.69%
1.74%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Wayne

About TFX

teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. headquartered in wayne, pa, teleflex employs approximately 12,000 people worldwide and serves healthcare providers in more than 150 countries.